DÉRIVÉ DE QUINAZOLINE DIMÈRE SUBSTITUÉ, SA PRÉPARATION ET SON UTILISATION DANS DES COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DU DIABÈTE DE TYPE I ET II
The present invention relates to substituted quinazolines of formula (I) wherein X and Y are defined as in claim 1, the tautomers, stereoisomers, mixtures and salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).